Study: Aspirin cuts death risk in prostate cancer patients

10/25/2010 | WebMD

Preliminary results from a large study show that anti-coagulants, particularly aspirin, reduced the risk of death by more than 50% for men with prostate cancer that had not spread beyond the gland. Patients who took anti-coagulants were also less likely to experience cancer recurrence than those who didn't take such drugs.

View Full Article in:

WebMD

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC